Metastatic Pancreatic Cancer Treatment Market - Global Outlook and Forecast 2021-2027

April 2021 | 91 pages | ID: M0CBE1EABF20EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Metastatic Pancreatic Cancer Treatment in Global, including the following market information:

Global Metastatic Pancreatic Cancer Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Metastatic Pancreatic Cancer Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metastatic Pancreatic Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Metastatic Pancreatic Cancer Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Metastatic Pancreatic Cancer Treatment Market Segment Percentages, By Type, 2020 (%)

• Chemotherapy,
• Targeted Therapy
• Others

China Metastatic Pancreatic Cancer Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Metastatic Pancreatic Cancer Treatment Market Segment Percentages, By Application, 2020 (%)

• Exocrine
• Endocrine

Global Metastatic Pancreatic Cancer Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Metastatic Pancreatic Cancer Treatment Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Metastatic Pancreatic Cancer Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Metastatic Pancreatic Cancer Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Lilly
• Merck
• Celgene
• BioLineRx
• AstraZeneca
• Roche
• Amgen
• Pfizer
• Nantkwest, Inc

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Immuno-Cell Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Immuno-Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IMMUNO-CELL THERAPY OVERALL MARKET SIZE

2.1 Global Immuno-Cell Therapy Market Size: 2021 VS 2027
2.2 Global Immuno-Cell Therapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Immuno-Cell Therapy Players in Global Market
3.2 Top Global Immuno-Cell Therapy Companies Ranked by Revenue
3.3 Global Immuno-Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Immuno-Cell Therapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Immuno-Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-Cell Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Immuno-Cell Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Immuno-Cell Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Immuno-Cell Therapy Market Size Markets, 2021 & 2027
  4.1.2 Passive Immune (NK, LAK etc)
  4.1.3 Active Immune
4.2 By Type - Global Immuno-Cell Therapy Revenue & Forecasts
  4.2.1 By Type - Global Immuno-Cell Therapy Revenue, 2016-2021
  4.2.2 By Type - Global Immuno-Cell Therapy Revenue, 2022-2027
  4.2.3 By Type - Global Immuno-Cell Therapy Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Immuno-Cell Therapy Market Size, 2021 & 2027
  5.1.2 Oncology
  5.1.3 Cardiovascular Disease (CVD)
  5.1.4 Orthopedic
  5.1.5 Wound Healing
  5.1.6 Others
5.2 By Application - Global Immuno-Cell Therapy Revenue & Forecasts
  5.2.1 By Application - Global Immuno-Cell Therapy Revenue, 2016-2021
  5.2.2 By Application - Global Immuno-Cell Therapy Revenue, 2022-2027
  5.2.3 By Application - Global Immuno-Cell Therapy Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Immuno-Cell Therapy Market Size, 2021 & 2027
6.2 By Region - Global Immuno-Cell Therapy Revenue & Forecasts
  6.2.1 By Region - Global Immuno-Cell Therapy Revenue, 2016-2021
  6.2.2 By Region - Global Immuno-Cell Therapy Revenue, 2022-2027
  6.2.3 By Region - Global Immuno-Cell Therapy Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Immuno-Cell Therapy Revenue, 2016-2027
  6.3.2 US Immuno-Cell Therapy Market Size, 2016-2027
  6.3.3 Canada Immuno-Cell Therapy Market Size, 2016-2027
  6.3.4 Mexico Immuno-Cell Therapy Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Immuno-Cell Therapy Revenue, 2016-2027
  6.4.2 Germany Immuno-Cell Therapy Market Size, 2016-2027
  6.4.3 France Immuno-Cell Therapy Market Size, 2016-2027
  6.4.4 U.K. Immuno-Cell Therapy Market Size, 2016-2027
  6.4.5 Italy Immuno-Cell Therapy Market Size, 2016-2027
  6.4.6 Russia Immuno-Cell Therapy Market Size, 2016-2027
  6.4.7 Nordic Countries Immuno-Cell Therapy Market Size, 2016-2027
  6.4.8 Benelux Immuno-Cell Therapy Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Immuno-Cell Therapy Revenue, 2016-2027
  6.5.2 China Immuno-Cell Therapy Market Size, 2016-2027
  6.5.3 Japan Immuno-Cell Therapy Market Size, 2016-2027
  6.5.4 South Korea Immuno-Cell Therapy Market Size, 2016-2027
  6.5.5 Southeast Asia Immuno-Cell Therapy Market Size, 2016-2027
  6.5.6 India Immuno-Cell Therapy Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Immuno-Cell Therapy Revenue, 2016-2027
  6.6.2 Brazil Immuno-Cell Therapy Market Size, 2016-2027
  6.6.3 Argentina Immuno-Cell Therapy Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Immuno-Cell Therapy Revenue, 2016-2027
  6.7.2 Turkey Immuno-Cell Therapy Market Size, 2016-2027
  6.7.3 Israel Immuno-Cell Therapy Market Size, 2016-2027
  6.7.4 Saudi Arabia Immuno-Cell Therapy Market Size, 2016-2027
  6.7.5 UAE Immuno-Cell Therapy Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 MEDINET Co
  7.1.1 MEDINET Co Corporate Summary
  7.1.2 MEDINET Co Business Overview
  7.1.3 MEDINET Co Immuno-Cell Therapy Major Product Offerings
  7.1.4 MEDINET Co Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.1.5 MEDINET Co Key News
7.2 Erytech
  7.2.1 Erytech Corporate Summary
  7.2.2 Erytech Business Overview
  7.2.3 Erytech Immuno-Cell Therapy Major Product Offerings
  7.2.4 Erytech Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.2.5 Erytech Key News
7.3 Seta Clinic Group
  7.3.1 Seta Clinic Group Corporate Summary
  7.3.2 Seta Clinic Group Business Overview
  7.3.3 Seta Clinic Group Immuno-Cell Therapy Major Product Offerings
  7.3.4 Seta Clinic Group Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.3.5 Seta Clinic Group Key News
7.4 Takeda
  7.4.1 Takeda Corporate Summary
  7.4.2 Takeda Business Overview
  7.4.3 Takeda Immuno-Cell Therapy Major Product Offerings
  7.4.4 Takeda Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.4.5 Takeda Key News
7.5 SBI Holdings
  7.5.1 SBI Holdings Corporate Summary
  7.5.2 SBI Holdings Business Overview
  7.5.3 SBI Holdings Immuno-Cell Therapy Major Product Offerings
  7.5.4 SBI Holdings Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.5.5 SBI Holdings Key News
7.6 Oxford BioTherapeutics
  7.6.1 Oxford BioTherapeutics Corporate Summary
  7.6.2 Oxford BioTherapeutics Business Overview
  7.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Major Product Offerings
  7.6.4 Oxford BioTherapeutics Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.6.5 Oxford BioTherapeutics Key News
7.7 Fate Therapeutics
  7.7.1 Fate Therapeutics Corporate Summary
  7.7.2 Fate Therapeutics Business Overview
  7.7.3 Fate Therapeutics Immuno-Cell Therapy Major Product Offerings
  7.4.4 Fate Therapeutics Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.7.5 Fate Therapeutics Key News
7.8 Gilead Sciences
  7.8.1 Gilead Sciences Corporate Summary
  7.8.2 Gilead Sciences Business Overview
  7.8.3 Gilead Sciences Immuno-Cell Therapy Major Product Offerings
  7.8.4 Gilead Sciences Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.8.5 Gilead Sciences Key News
7.9 Novartis
  7.9.1 Novartis Corporate Summary
  7.9.2 Novartis Business Overview
  7.9.3 Novartis Immuno-Cell Therapy Major Product Offerings
  7.9.4 Novartis Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.9.5 Novartis Key News
7.10 Osiris
  7.10.1 Osiris Corporate Summary
  7.10.2 Osiris Business Overview
  7.10.3 Osiris Immuno-Cell Therapy Major Product Offerings
  7.10.4 Osiris Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.10.5 Osiris Key News
7.11 Vericel Corporation
  7.11.1 Vericel Corporation Corporate Summary
  7.11.2 Vericel Corporation Business Overview
  7.11.3 Vericel Corporation Immuno-Cell Therapy Major Product Offerings
  7.11.4 Vericel Corporation Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.11.5 Vericel Corporation Key News
7.12 Fujifilm Cellular Dynamics
  7.12.1 Fujifilm Cellular Dynamics Corporate Summary
  7.12.2 Fujifilm Cellular Dynamics Business Overview
  7.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Major Product Offerings
  7.12.4 Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.12.5 Fujifilm Cellular Dynamics Key News
7.13 JCR Pharmaceuticals
  7.13.1 JCR Pharmaceuticals Corporate Summary
  7.13.2 JCR Pharmaceuticals Business Overview
  7.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Major Product Offerings
  7.13.4 JCR Pharmaceuticals Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.13.5 JCR Pharmaceuticals Key News
7.14 Beike Biotechnology
  7.14.1 Beike Biotechnology Corporate Summary
  7.14.2 Beike Biotechnology Business Overview
  7.14.3 Beike Biotechnology Immuno-Cell Therapy Major Product Offerings
  7.14.4 Beike Biotechnology Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.14.5 Beike Biotechnology Key News
7.15 Golden Meditech
  7.15.1 Golden Meditech Corporate Summary
  7.15.2 Golden Meditech Business Overview
  7.15.3 Golden Meditech Immuno-Cell Therapy Major Product Offerings
  7.15.4 Golden Meditech Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.15.5 Golden Meditech Key News
7.16 Guanhao Biotech
  7.16.1 Guanhao Biotech Corporate Summary
  7.16.2 Guanhao Biotech Business Overview
  7.16.3 Guanhao Biotech Immuno-Cell Therapy Major Product Offerings
  7.16.4 Guanhao Biotech Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.16.5 Guanhao Biotech Key News
7.17 Beroni Group
  7.17.1 Beroni Group Corporate Summary
  7.17.2 Beroni Group Business Overview
  7.17.3 Beroni Group Immuno-Cell Therapy Major Product Offerings
  7.17.4 Beroni Group Immuno-Cell Therapy Revenue in Global (2016-2021)
  7.17.5 Beroni Group Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Metastatic Pancreatic Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Metastatic Pancreatic Cancer Treatment Market Drivers in Global Market
Table 3. Metastatic Pancreatic Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Metastatic Pancreatic Cancer Treatment in Global Market
Table 5. Top Metastatic Pancreatic Cancer Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Metastatic Pancreatic Cancer Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Metastatic Pancreatic Cancer Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Metastatic Pancreatic Cancer Treatment Product Type
Table 9. List of Global Tier 1 Metastatic Pancreatic Cancer Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metastatic Pancreatic Cancer Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Metastatic Pancreatic Cancer Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Metastatic Pancreatic Cancer Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Metastatic Pancreatic Cancer Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Metastatic Pancreatic Cancer Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Metastatic Pancreatic Cancer Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Metastatic Pancreatic Cancer Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Lilly Corporate Summary
Table 31. Lilly Metastatic Pancreatic Cancer Treatment Product Offerings
Table 32. Lilly Metastatic Pancreatic Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Merck Corporate Summary
Table 34. Merck Metastatic Pancreatic Cancer Treatment Product Offerings
Table 35. Merck Metastatic Pancreatic Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Celgene Corporate Summary
Table 37. Celgene Metastatic Pancreatic Cancer Treatment Product Offerings
Table 38. Celgene Metastatic Pancreatic Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 39. BioLineRx Corporate Summary
Table 40. BioLineRx Metastatic Pancreatic Cancer Treatment Product Offerings
Table 41. BioLineRx Metastatic Pancreatic Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca Metastatic Pancreatic Cancer Treatment Product Offerings
Table 44. AstraZeneca Metastatic Pancreatic Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Roche Corporate Summary
Table 46. Roche Metastatic Pancreatic Cancer Treatment Product Offerings
Table 47. Roche Metastatic Pancreatic Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Amgen Corporate Summary
Table 49. Amgen Metastatic Pancreatic Cancer Treatment Product Offerings
Table 50. Amgen Metastatic Pancreatic Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Metastatic Pancreatic Cancer Treatment Product Offerings
Table 53. Pfizer Metastatic Pancreatic Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Nantkwest, Inc Corporate Summary
Table 55. Nantkwest, Inc Metastatic Pancreatic Cancer Treatment Product Offerings
Table 56. Nantkwest, Inc Metastatic Pancreatic Cancer Treatment Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Metastatic Pancreatic Cancer Treatment Segment by Type
Figure 2. Metastatic Pancreatic Cancer Treatment Segment by Application
Figure 3. Global Metastatic Pancreatic Cancer Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Metastatic Pancreatic Cancer Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Metastatic Pancreatic Cancer Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metastatic Pancreatic Cancer Treatment Revenue in 2020
Figure 8. By Type - Global Metastatic Pancreatic Cancer Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Metastatic Pancreatic Cancer Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Metastatic Pancreatic Cancer Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Metastatic Pancreatic Cancer Treatment Revenue Market Share, 2016-2027
Figure 12. US Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Metastatic Pancreatic Cancer Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Metastatic Pancreatic Cancer Treatment Revenue Market Share, 2016-2027
Figure 24. China Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Metastatic Pancreatic Cancer Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Metastatic Pancreatic Cancer Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Metastatic Pancreatic Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Lilly Metastatic Pancreatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Merck Metastatic Pancreatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Celgene Metastatic Pancreatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BioLineRx Metastatic Pancreatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. AstraZeneca Metastatic Pancreatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Roche Metastatic Pancreatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Amgen Metastatic Pancreatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Pfizer Metastatic Pancreatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)